Cargando…
Allopurinol in combination with thiopurine induces mucosal healing and improves clinical and metabolic outcomes in IBD
BACKGROUND: Thiopurines, azathioprine (AZA) and 6-mercaptopurine (6-MP) are common maintenance medications for inflammatory bowel disease (IBD). Excessive methylation via thiopurine methyltransferase (TPMT) frequently causes therapeutic failure. Allopurinol reduces excessive 6-methyl-mercaptopurine...
Autores principales: | Moreau, Brigitte, Clement, Pierre, Theoret, Yves, Seidman, Ernest G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673019/ https://www.ncbi.nlm.nih.gov/pubmed/29147133 http://dx.doi.org/10.1177/1756283X17733657 |
Ejemplares similares
-
Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro
por: Broekman, Mark M. T. J., et al.
Publicado: (2015) -
A practical guide to thiopurine prescribing and monitoring in IBD
por: Warner, Ben, et al.
Publicado: (2018) -
Safety and Efficacy of Split-Dose Thiopurine vs Low-Dose Thiopurine-Allopurinol Cotherapy in Pediatric Inflammatory Bowel Disease
por: Cococcioni, Lucia, et al.
Publicado: (2022) -
Nodular regenerative hyperplasia in inflammatory bowel disease patients with allopurinol–thiopurine cotherapy
por: Simsek, Melek, et al.
Publicado: (2018) -
Two Brothers with Skewed Thiopurine Metabolism in Ulcerative Colitis Treated Successfully with Allopurinol and Mercaptopurine Dose Reduction
por: Hoentjen, Frank, et al.
Publicado: (2011)